SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pai YC, Rymer WZ, Chang RW, Sharma L. Effect of age and osteoarthritis on knee proprioception. Arthritis Rheum 1997; 40: 22605.
  • 2
    Barrett DS, Cobb AG, Bentley G. Joint proprioception in normal, osteoarthritic and replaced knees. J Bone Joint Surg Br 1991; 73: 536.
  • 3
    Hurley MV, Scott DL, Rees J, Newham DJ. Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis 1997; 56: 6418.
  • 4
    Sharma L. Proprioceptive impairment in knee osteoarthritis. Rheum Dis Clin North Am 1999; 25: 299314.
  • 5
    Shakoor N, Moisio K. A biomechanical approach to musculoskeletal disease. Best Pract Res Clin Rheumatol 2004; 18: 17386.
  • 6
    Lephart SM. Proprioception and neuromuscular control in joint stability. Champaign (IL): Human Kinetics; 2000.
  • 7
    Grob KR, Kuster MS, Higgins SA, Lloyd DG, Yata H. Lack of correlation between different measurements of proprioception in the knee. J Bone Joint Surg Br 2002; 84: 6148.
  • 8
    Goetz CG. Textbook of clinical neurology. 3rd ed. Philadelphia: WB Saunders; 2007.
  • 9
    Davis EA, Jones TW, Walsh P, Byrne GC. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes Care 1997; 20: 144853.
  • 10
    Olsen BS, Nir M, Kjaer I, Volund A, Mortensen HB. Elevated vibration perception threshold in young patients with type 1 diabetes in comparison to non-diabetic children and adolescents. Diabet Med 1994; 11: 88892.
  • 11
    Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg 2004; 43: 8792.
  • 12
    Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 108596.
  • 13
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 103949.
  • 14
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 183340.
  • 15
    Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1995; 38: 15005.
  • 16
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494502.
  • 17
    Frenette B, Mergler D, Ferraris J. Measurement precision of a portable instrument to assess vibrotactile perception threshold. Euro J App Physiol Occup Physiol 1990; 61: 38691.
  • 18
    Van Deursen RW, Sanchez MM, Derr JA, Becker MB, Ulbrecht JS, Cavanagh PR. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med 2001; 18: 46975.
  • 19
    Armstrong DG, Hussain SK, Middleton J, Peters EJ, Wunderlich RP, Lavery LA. Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination? Ostomy Wound Manage 1976; 44: 704.